Ensysce Biosciences, Inc. ENSC
NASDAQ · United States · Health Technology
$0.3950-0.00 (-1.20%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-13 | -0.20 | -0.20 | 0.0% | $1.20M | 0.0% | +0.3%$0.40→$0.40 |
| Q1 2026 | 2026-05-15 | -0.52 | -0.73 | +28.8% | — | — | +14.4%$0.28→$0.32 |
| Q4 2025 | 2026-03-30 | -0.75 | -1.26 | +40.5% | — | — | +2.1%$0.53→$0.54 |
| Q3 2025 | 2025-11-14 | -1.29 | -0.93 | -38.7% | — | — | -5.3%$2.07→$1.96 |
| Q2 2025 | 2025-08-13 | -0.79 | -1.28 | +38.3% | — | — | — |
| Q1 2025 | 2025-05-13 | -1.39 | -1.53 | +9.2% | — | — | — |
| Q4 2024 | 2025-03-10 | -2.90 | -1.95 | -48.7% | — | — | — |
| Q3 2024 | 2024-11-12 | 1.05 | -2.55 | +141.2% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.